A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study with an open-label period and long-term extension to assess the efficacy and safety of rilzabrutinib in participants with warm autoimmune hemolytic anemia (wAIHA)
2026-09-14
عنوان الدراسة
A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study with an open-label period and long-term extension to assess the efficacy and safety of rilzabrutinib in participants with warm autoimmune hemolytic anemia (wAIHA)
داعم الدراسة
Arabia trading limited MB: Sanofi Arabia Trading Company Limited
دواء الدراسة
Rilzabrutinib SAR444671
رقم بروتوكول الدراسة
EFC17360
حالة الدراسة
Ongoing
موقع الدراسة
1.King Saud University Medical City -Riyadh 2.King Faisal Specialist Hospital and Researech Center - Jeddah
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.